Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Nicox SA.
  6. News
  7. Summary
    COX   FR0013018124

NICOX SA.

(COX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about NICOX SA.
01/06NICOX : Half-year liquidity contract statement for NICOX
AQ
01/05Nicox Secures European Patent For Allergic Conjunctivitis Treatment
MT
01/05Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030
AQ
2021NICOX SA. : Monthly statement on outstanding equity shares and voting rights
CO
2021Nicox Screens First Patient in China in Late-Stage Trial For Glaucoma Treatment
MT
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
AQ
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
CI
2021Nicox Appoints Novartis Executive as Chief Scientific Officer
MT
2021Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-c..
AQ
2021Nicox Appoints Doug Hubatsch as New Chief Scientific Officer to Lead Clinical and Non-C..
CI
2021NICOX SA. : Nomination
CO
2021Nicox Raises $17 Million in Share Placement, Restructures Kreos Bond Financing Deal
MT
2021Nicox Restructures Kreos Capital Bond Financing Agreement and Raises Ç15 Million in Pri..
AQ
2021Number of voting rrights as of November 30, 2021
AQ
2021Nicox Reports Positive Results For Dry Eye Treatment Trial
MT
More most relevant news
All news about NICOX SA.
01/06NICOX : Half-year liquidity contract statement for NICOX
AQ
01/05Nicox Secures European Patent For Allergic Conjunctivitis Treatment
MT
01/05Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030
AQ
2021NICOX SA. : Monthly statement on outstanding equity shares and voting rights
CO
2021Nicox Screens First Patient in China in Late-Stage Trial For Glaucoma Treatment
MT
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
AQ
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
CI
2021GLOBAL MARKETS LIVE : General Motors, JP Morgan, Pfizer, Novavax, Ford...
2021Nicox Appoints Novartis Executive as Chief Scientific Officer
MT
2021Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-c..
AQ
More news
News in other languages on NICOX SA.
01/05NICOX : plus forte hausse du SRD à la clôture du mercredi 5 janvier 2022
01/05NICOX : plus forte hausse du SRD à la mi-séance du mercredi 5 janvier 2022
01/05CAC40 : gagne 0,3%, la chasse aux records se poursuit
01/05LA VALEUR DU JOUR À PARIS NICOX : renforcement de la protection intellectuelle de Zerviat..
01/05NICOX : entouré après l'obtention d'un brevet en Europe
01/05Les valeurs à suivre mercredi 5 janvier 2022 à Paris -
01/05La baisse cherche à emmerder la hausse
01/05EN DIRECT DES MARCHES : Amundi, Publicis, ADP, Atos, Korian, Toyota, Samsung, BMW, Sony...
01/05Nicox obtient un brevet européen pour un traitement de la conjonctivite allergique
01/05NICOX : A suivre aujourd'hui
More news
Press releases
01/06NICOX : Half-year liquidity contract statement for NICOX
AQ
01/05Nicox European Patent Seals ZERVIATE Major Market Coverage to 2030
AQ
2021Nicox Announces First Patient in China screened in the ongoing NCX 470 Denali Phase 3 T..
AQ
2021Nicox Appoints Doug Hubatsch as new Chief Scientific Officer to lead Clinical and Non-c..
AQ
2021Nicox Restructures Kreos Capital Bond Financing Agreement and Raises Ç15 Million in Pri..
AQ
More press releases
Upcoming event on NICOX SA.
03/10/22